Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × INDUSTRY × NET × Clear all

Status

Completed 63 Recruiting 25 Active not recruiting 15 Terminated 14 Unknown 5 Not yet recruiting 2 Approved for marketing 2 Withdrawn 1 No longer available 1 Enrolling by invitation 1

Sponsor Class

OTHER 3 INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Dermatologic 18 Gastrointestinal 17 Thoracic 16 Other hematologic neoplasm 16 Lymphoid 14 Plasma cell 13 CNS 11 Genitourinary 10 Breast 10 Sarcoma 7 Tumor-Agnostic 6 Other solid neoplasm 6 Myeloid 5 Gynecologic 3 Head & Neck 2 NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04814732 2024-04-12

Expanded Access Program of Surufatinib

Hutchmed

No longer available

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡